Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit

Wang,Jianhong; Hu,Zicheng; Yang,Shu; Liu,Chengchun; Yang,Haimei; Wang,Duozi; Guo,Fuqiang

doi:10.3892/etm.2018.6213

Inflammatory cytokines and cells are potential markers for patients with cerebral apoplexy in intensive care unit

Authors:
- Jianhong Wang
- Zicheng Hu
- Shu Yang
- Chengchun Liu
- Haimei Yang
- Duozi Wang
- Fuqiang Guo
View Affiliations

Affiliations: Department of Neurology, The Affiliated Hospital of University of Electronic Science and Technology, Sichuan Provincial People's Hospital, Chengdu, Sichuan 610054, P.R. China, Department of Neurology, Daping Hospital, Third Military Medical University, Chongqing 400042, P.R. China
Published online on: May 23, 2018 https://doi.org/10.3892/etm.2018.6213
Pages: 1014-1020

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Cerebral apoplexy is a disease caused by obstruction of the blood circulation in the brain. Evidence has indicated that inflammatory cytokines are implicated in ischaemic cerebral apoplexy and are regarded as a general cardiovascular risk factor, which may be a possible immediate trigger, a component of the response to tissue injury and a therapeutic target. The present study investigated changes of inflammatory cytokines and cells in patients with cerebral apoplexy at the intensive care unit (ICU). The plasma concentrations of inflammatory cytokines, including tumor necrosis factor (TNF)‑α, interleukin (IL)‑4, IL‑6, IL‑8, IL‑10, IL‑1β and IL‑17A were evaluated using ELISA. Changes in the plasma concentrations of inflammatory cells were detected by using flow cytometry. The results indicated that serum levels of TNF‑α, IL‑4, IL‑8, IL‑1β and IL‑17A were upregulated in patients with cerebral apoplexy compared with those in healthy individuals, while those of IL‑6 and IL‑10 were downregulated. Furthermore, it was demonstrated that the plasma concentration of lymphocytes, granulocytes and mononuclear cells was decreased in patients with cerebral apoplexy in the ICU compared with that in healthy individuals. Of note, humoral as well as cellular inflammatory cytokines were evidently increased in patients with cerebral apoplexy in ICU. In conclusion, the present study provided evidence that inflammatory cytokines and inflammatory cells are upregulated, while anti‑inflammatory cytokines are downregulated in patients with cerebral apoplexy in an ICU setting. These results suggest that anti‑inflammatory interventions may be beneficial either in the prevention or acute treatment of patients with cerebral apoplexy.

View Figures

View References

1	Jeon BC, Park YS, Oh HS, Kim YS and Chun BK: Pituitary apoplexy complicated by chemical meningitis and cerebral infarction. J Korean Med Sci. 22:1085–1089. 2007. View Article : Google Scholar : PubMed/NCBI
2	Dev R, Singh SK, Sharma MC, Khetan P and Chugh A: Post traumatic pituitary apoplexy with contiguous intra cerebral hematoma operated through endonasal route-a case report. Pituitary. 10:291–294. 2007. View Article : Google Scholar : PubMed/NCBI
3	Ben-Nakhi A, Muttikkal TJ, Chavan VN, Al-Turkomani AY and Gupta R: Pituitary apoplexy: A rare cause of cerebral infarction. A case report. Neuroradiol J. 21:661–665. 2008.
4	Ahmed SK and Semple PL: Cerebral ischaemia in pituitary apoplexy. Acta Neurochir (Wien). 150:1193–1196. 2008. View Article : Google Scholar : PubMed/NCBI
5	Cerase A, Tarantino A, Muzii VF, Vittori C and Venturi C: Vasospasm and cerebral infarction from pituitary apoplexy. A case report. Neuroradiol J. 23:321–324. 2010.
6	López Hernández N, García Escrivá A, Moltó Jordá JM and García Barragán N: Massive cerebral infarction secondary to apoplexy due to pituitary adenoma. Neurologia. 23:248–255. 2008.(In Spanish). PubMed/NCBI
7	Das NK, Behari S and Banerji D: Pituitary apoplexy associated with acute cerebral infarct. J Clin Neurosci. 15:1418–1420. 2008. View Article : Google Scholar : PubMed/NCBI
8	Zhang C, Feng F, Zhu Y, Wang R and Xing B: Cerebral infarction caused by pituitary apoplexy: Case report and review of literature. Turk Neurosurg. 24:782–787. 2014.PubMed/NCBI
9	de Silva DA, Woon FP, Gan HY, Cameron J, Kingwell B, Koh TH, Chen C, Chang HM and Wong MC: Arterial stiffness, metabolic syndrome and inflammation amongst Asian ischaemic stroke patients. Eur J Neurol. 15:872–875. 2008. View Article : Google Scholar : PubMed/NCBI
10	Chamorro A and Planas AM: Inflammation-mediated damage as a potential therapeutic target in acute ischemic stroke. Ernst Schering Res Found Workshop. pp. 185–204. 2004, PubMed/NCBI
11	Chamorro A: Role of inflammation in stroke and atherothrombosis. Cerebrovasc Dis. 17(Suppl 3): S1–S5. 2004. View Article : Google Scholar
12	Zhang W and Stanimirovic D: Current and future therapeutic strategies to target inflammation in stroke. Curr Drug Targets Inflamm Allergy. 1:151–166. 2002. View Article : Google Scholar : PubMed/NCBI
13	McColl BW, Allan SM and Rothwell NJ: Systemic infection, inflammation and acute ischemic stroke. Neuroscience. 158:1049–1061. 2009. View Article : Google Scholar : PubMed/NCBI
14	Filipova J, Rihova L, Vsianska P, Kufova Z, Kryukova E, Kryukov F and Hajek R: Flow cytometry in immunoglobulin light chain amyloidosis: Short review. Leuk Res, Jul 13, 2015 (Epub ahead of print).
15	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
16	Kaplan RC, McGinn AP, Baird AE, Hendrix SL, Kooperberg C, Lynch J, Rosenbaum DM, Johnson KC, Strickler HD and Wassertheil-Smoller S: Inflammation and hemostasis biomarkers for predicting stroke in postmenopausal women: The women's health initiative observational study. J Stroke Cerebrovasc Dis. 17:344–355. 2008. View Article : Google Scholar : PubMed/NCBI
17	McColl BW, Rothwell NJ and Allan SM: Systemic inflammation alters the kinetics of cerebrovascular tight junction disruption after experimental stroke in mice. J Neurosci. 28:9451–9462. 2008. View Article : Google Scholar : PubMed/NCBI
18	Theodorou GL, Marousi S, Ellul J, Mougiou A, Theodori E, Mouzaki A and Karakantza M: T helper 1 (Th1)/Th2 cytokine expression shift of peripheral blood CD4+ and CD8+ T cells in patients at the post-acute phase of stroke. Clin Exp Immunol. 152:456–463. 2008. View Article : Google Scholar : PubMed/NCBI
19	Caso JR, Pradillo JM, Hurtado O, Lorenzo P, Moro MA and Lizasoain I: Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 115:1599–1608. 2007. View Article : Google Scholar : PubMed/NCBI
20	Lip GY, Patel JV, Hughes E and Hart RG: High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: Relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke. 38:1229–1237. 2007. View Article : Google Scholar : PubMed/NCBI
21	Castillo J, Alvarez-Sabin J, Martinez-Vila E, Montaner J, Sobrino T and Vivancos J; MITICO Study Investigators: Inflammation markers and prediction of post-stroke vascular disease recurrence: The MITICO study. J Neurol. 256:217–224. 2009. View Article : Google Scholar : PubMed/NCBI
22	Nguyen H, Aum D, Mashkouri S, Rao G, Vega Gonzales-Portillo JD, Reyes S and Borlongan CV: Growth factor therapy sequesters inflammation in affording neuroprotection in cerebrovascular diseases. Expert Rev Neurother. 16:915–926. 2016. View Article : Google Scholar : PubMed/NCBI
23	Tong Y, Han J, Guan X, Lu Z, Miao X, Ye J, Hou SY, Zhang Y, Geng Y, Li Y, et al: Association of IL-1 receptor antagonist gene VNTR polymorphism with ischemic stroke in the Chinese Uyghur population. Biochem Genet. 51:698–706. 2013. View Article : Google Scholar : PubMed/NCBI
24	Sumbria RK, Boado RJ and Pardridge WM: Brain protection from stroke with intravenous TNFα decoy receptor-Trojan horse fusion protein. J Cereb Blood Flow Metab. 32:1933–1938. 2012. View Article : Google Scholar : PubMed/NCBI
25	Al-Bahrani A, Taha S, Shaath H and Bakhiet M: TNF-alpha and IL-8 in acute stroke and the modulation of these cytokines by antiplatelet agents. Curr Neurovasc Res. 4:31–37. 2007. View Article : Google Scholar : PubMed/NCBI
26	Ma S, Zhong D, Chen H, Zheng Y, Sun Y, Luo J, Li H, Li G and Yin Y: The immunomodulatory effect of bone marrow stromal cells (BMSCs) on interleukin (IL)-23/IL-17-mediated ischemic stroke in mice. J Neuroimmunol. 257:28–35. 2013. View Article : Google Scholar : PubMed/NCBI
27	Kwan J, Horsfield G, Bryant T, Gawne-Cain M, Durward G, Byrne CD and Englyst NA: IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke. Exp Gerontol. 48:960–965. 2013. View Article : Google Scholar : PubMed/NCBI
28	Fouda AY, Kozak A, Alhusban A, Switzer JA and Fagan SC: Anti-inflammatory IL-10 is upregulated in both hemispheres after experimental ischemic stroke: Hypertension blunts the response. Exp Transl Stroke Med. 5:122013. View Article : Google Scholar : PubMed/NCBI
29	Sieber MW, Jaenisch N, Brehm M, Guenther M, Linnartz-Gerlach B, Neumann H, Witte OW and Frahm C: Attenuated inflammatory response in triggering receptor expressed on myeloid cells 2 (TREM2) knock-out mice following stroke. PLoS One. 8:e529822013. View Article : Google Scholar : PubMed/NCBI
30	Jin R, Yang G and Li G: Inflammatory mechanisms in ischemic stroke: Role of inflammatory cells. J Leukoc Biol. 87:779–789. 2010. View Article : Google Scholar : PubMed/NCBI